Neda Safarzadeh is the Vice President, Head of Investor relations/Public relations/Marketing at Arcturus Therapeutics. She has served at Arcturus Therapeutics since company’s inception, joining company’ co-founders in 2013. During her time at Arcturus, she helped the management team raise over $500 Million from institutional investors, capturing quality analyst coverage along with media visibility in U.S. and abroad.
Prior to Arcturus Therapeutics, she was a Senior Scientist at Nitto Denko working on novel RNA medicines to treat liver fibrosis, co-authoring a key patent which was intellectually contributed to the discovery of new formulation to encapsulate siRNA into liposomal formulation for Liver Fibrosis. Her academic training includes a B.S. degree in Chemical Engineering from the University of California San Diego.
